Advertisement
Screener

Serina Therapeutics, Inc. (SER) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Serina Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Serina Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $17.95M went out.
  • Fiscal year ended 2025-12-31: from investing, $59.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $17.41M came in.
  • Fiscal year ended 2025-12-31: change in cash, $616.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$17.95M-$59.00K$0.00$15.00K$17.40M*-$616.00K
2024-12-31-$17.14M-$22.00K$3.04M$12.00K$10.16M*-$3.95M
2023-12-31-$2.48M-$504.00K$0.00$15.00K$10.05M*$7.09M
2022-12-31-$5.94M$6.00M$61.00K
2021-12-31-$7.86M$666.00K$7.00M$496.00K$57.00K
2020-12-31-$7.82M-$20.00K$433.00K$5.53M*-$1.88M
2019-12-31-$10.16M-$361.00K$1.80M$7.80M-$3.33M*-$4.25M
2018-12-31-$8.00M$1.33M$5.00M$1.00M*-$668.00K
2017-12-31-$6.29M$5.00K$10.00M$3.27M*$7.12M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$6.68M*-$28.00K*$1.00K*$5.20M*
2026-03-31-$4.57M-$25.00K$8.00K$26.05M*$21.47M
2025-12-31-$6.03M*$0.00*$0.00*$5.00K*
2025-09-30-$3.85M*-$13.00K*$0.00*$8.00K*$6.44M*
2025-06-30-$3.75M*-$46.00K*$0.00*$1.00K*$5.57M*
2025-03-31-$4.32M$0.00$0.00$4.92M$595.00K
2024-12-31-$4.59M*-$5.00K*$110.00K*-$78.00K*$5.00M*
2024-09-30-$2.96M*-$3.00K*$8.00K*$86.00K*
2024-06-30-$8.01M*$0.00*$525.00K*$0.00*$4.84M*
2024-03-31-$1.58M-$14.00K$2.40M$0.00$1.14M
2023-12-31$121.00K*-$70.00K*$0.00*$0.00*
2023-09-30-$1.02M*-$119.00K*-$13.50M*$14.00K*
2023-06-30-$864.00K*$9.69M*$2.00M*
2023-03-31-$709.00K-$10.00M$11.50M-$1.41M*$9.38M
2022-12-31-$1.32M*$1.50M*
2022-09-30-$1.24M*$1.00M*
2022-06-30-$1.75M*$2.00M*
2022-03-31-$1.64M$1.50M-$136.00K
2021-12-31-$1.65M*$0.00*$1.50M*$0.00*
2021-09-30-$1.88M*$0.00*$2.00M*$0.00*
2021-06-30-$1.69M*$0.00*$1.50M*$0.00*
2021-03-31-$2.63M$666.00K$2.00M$496.00K$282.00K
2020-12-31-$1.62M*$0.00*$0.00*$992.00K*
2020-09-30-$1.89M*-$12.00K*$0.00*$1.98M*
2020-06-30-$2.24M*-$4.00K*$2.81M*
2020-03-31-$2.06M-$4.00K-$1.88M
2019-12-31-$2.41M*-$295.00K*$1.29M*
2019-09-30-$2.37M*-$157.00K*
2019-06-30-$2.76M*$94.00K*
2019-03-31-$2.62M-$3.00K$4.50M*$1.88M
2018-12-31-$2.05M*$3.00K*$0.00*
2018-09-30-$1.78M*-$1.08M*$0.00*
2018-06-30-$2.16M*-$12.00K*$5.00M*
2018-03-31-$2.00M$2.41M$737.00K*$1.15M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Xilio Therapeutics, Inc. (XLO)United States$0.052B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
TALPHERA, INC. (TLPH)United States$0.060B